Mechanisms of E protein transcription factor-dependent iNKT cell expansion and differentiation
Mechanisms of E protein transcription factor-dependent iNKT cell expansion and differentiation
批准号:
9242168
负责人:
BARBARA L. KEE
金额:
$39.69万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-12-19 至 2021-11-30
关键词:
Alpha CellAntigensApplications GrantsAsthmaAtherosclerosisAutoimmune DiseasesAutoimmunityBCL6 geneCD4 Positive T LymphocytesCD8-Positive T-LymphocytesCD8B1 geneCell CountCell Differentiation processCell LineageCell physiologyCellsCytotoxic T-LymphocytesDataDendritic CellsDevelopmentDiseaseE proteinEctopic ExpressionEffector CellEnsureFailureGATA3 geneGene ExpressionGene Expression ProfileGene TargetingGenetic TranscriptionGlycolipidsGrantHypersensitivityID2 geneIL17 geneIL4 geneIgEImmuneImmune responseImmune systemInsulin-Dependent Diabetes MellitusInterceptInterferon Type IIInterleukin-7InvadedMalignant NeoplasmsMemoryMolecularMultiple SclerosisMusNatural ImmunityPhenotypePlayPopulationPredispositionProductionProteinsRegulationRepressionResearchRheumatoid ArthritisRoleSerumSpecific qualifier valueSystemSystemic Lupus ErythematosusT-Cell ReceptorT-LymphocyteT-Lymphocyte SubsetsTCF3 geneTestingTherapeuticTherapeutic AgentsThymus GlandTuberculosisWNT Signaling PathwayZNF145 geneadaptive immunityantimicrobialbasec-myc Proto-Oncogenescell typecytokineexperimental studygraft vs host diseasehelix-loop-helix protein differentiation inhibitorin vivoin vivo Modelinhibitor/antagonistinsightmutantnovelpathogenprotein Ethymocytetranscription factor
中文摘要
项目摘要
不变的自然杀伤T(iNKT)细胞是T淋巴细胞的一个子集,位于边界,
适应性免疫和先天性免疫。它们具有高度限制的T细胞受体(TCR),
检测由非经典MHC分子CD1d呈递的糖脂抗原,
对抗原或细胞因子的刺激反应迅速。NKT细胞在免疫调节中发挥重要作用。
抗微生物免疫反应,因为它们快速产生多种
细胞因子,它们被认为是癌症和其它疾病的治疗剂。
NKT细胞由于其独特的机制而获得其效应器表型
胸腺中的选择和分化。NKT细胞的效应物命运范围
我们才刚刚开始认识到控制NKT细胞的机制
效应子命运选择完全未知。我们的研究旨在了解
控制iNKT细胞发育的分子机制,重点是E
蛋白质转录因子,它们的抑制剂ID蛋白质,以及它们的下游靶标。
这些蛋白质是iNKT细胞数量和效应细胞命运选择的关键调节剂。
在本授权申请中,我们提出了实验来确定E2A的要求
在iNKT细胞发育中,两种基因的过度表达和表达不足的后果是:
推定的E2A靶基因,Lef1和Bcl 6。我们的研究将对我们的
了解NKT细胞的数量和功能如何调节。此外,我们的研究
将提供深入了解机制,操纵NKT细胞效应命运,从而
改变免疫反应。
英文摘要
Project Summary
Invariant natural killer T (iNKT) cells are a subset of T lymphocytes that sit at the boarder
of adaptive and innate immunity. They have highly restricted T cell receptors (TCRs) that
detect glycolipid antigen presented by the non-classical MHC molecule CD1d and they
respond rapidly to antigen or cytokine stimulation. NKT cells play an important role in
anti-microbial immune responses and because of their rapid production of multiple
cytokines they are being considered as therapeutic agents in cancer and other diseases.
NKT cells acquire their effector phenotype as a consequence of their unique mechanism
of selection and differentiation in the thymus. The range of effector fates that NKT cells
can acquire is only beginning to be appreciated but the mechanisms controlling NKT cell
effector fate choice are completely unknown. Our research is directed at understanding
the molecular mechanisms that control iNKT cell development with a focus on the E
protein transcription factors, their inhibitors the ID proteins, and their downstream targets.
These proteins are critical regulators of iNKT cell numbers and effector cell fate choice.
In this grant application we propose experiments to determine the requirements for E2A
in iNKT cell development an the consequences of over- and under-expression of two
putative E2A target genes, Lef1 and Bcl6. Our studies will have a major impact on our
understanding of how NKT cell number and function is regulated. In addition, our studies
will provide insight into mechanisms to manipulate NKT cell effector fate and thereby
alter immune responses at their inception.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Investigating Helios as a regulator of natural killer cell effector maturation
-
批准号:10608673
-
项目类别:
-
资助金额:$19.76万
-
财政年份:2023
-
负责人:BARBARA L. KEE
-
依托单位:
Identification of BATF function and targets during NK cell activation
-
批准号:10494220
-
项目类别:
-
资助金额:$24.6万
-
财政年份:2021
-
负责人:BARBARA L. KEE
-
依托单位:
Identification of BATF function and targets during NK cell activation
-
批准号:10354363
-
项目类别:
-
资助金额:$20.5万
-
财政年份:2021
-
负责人:BARBARA L. KEE
-
依托单位:
Mechanisms of E protein transcription factor-dependent iNKT cell expansion and differentiation
-
批准号:10065488
-
项目类别:
-
资助金额:$39.9万
-
财政年份:2016
-
负责人:BARBARA L. KEE
-
依托单位:
Molecular Mechanisms of Invariant Natural Killer T Cell Differentiation
-
批准号:10627307
-
项目类别:
-
资助金额:$32.47万
-
财政年份:2016
-
负责人:BARBARA L. KEE
-
依托单位:
Analysis of the role of immune deficiency in E2A-/- T cell lymphomagenesis
-
批准号:8959799
-
项目类别:
-
资助金额:$19.19万
-
财政年份:2015
-
负责人:BARBARA L. KEE
-
依托单位:
EZH2 in lymphoid lineage specification and commitment
-
批准号:8622415
-
项目类别:
-
资助金额:$19.75万
-
财政年份:2014
-
负责人:BARBARA L. KEE
-
依托单位:
Regulation of Lymphocyte Development by HLH Proteins
-
批准号:8791299
-
项目类别:
-
资助金额:$48.39万
-
财政年份:2014
-
负责人:BARBARA L. KEE
-
依托单位:
Transcriptional Control of Natural Killer Cell Development
-
批准号:10540688
-
项目类别:
-
资助金额:$48.6万
-
财政年份:2014
-
负责人:BARBARA L. KEE
-
依托单位:
Regulation of Lymphocyte Development by HLH Proteins
-
批准号:8638491
-
项目类别:
-
资助金额:$38.39万
-
财政年份:2014
-
负责人:BARBARA L. KEE
-
依托单位:
Regulation of Lymphocyte Development by HLH Proteins
-
批准号:8890271
-
项目类别:
-
资助金额:$5.0万
-
财政年份:2014
-
负责人:BARBARA L. KEE
-
依托单位:
Transcriptional Control of Natural Killer Cell Development
-
批准号:10318983
-
项目类别:
-
资助金额:$48.6万
-
财政年份:2014
-
负责人:BARBARA L. KEE
-
依托单位:
EZH2 in lymphoid lineage specification and commitment
-
批准号:8788383
-
项目类别:
-
资助金额:$23.7万
-
财政年份:2014
-
负责人:BARBARA L. KEE
-
依托单位:
Transcriptional Control of Natural Killer Cell Development
-
批准号:10084246
-
项目类别:
-
资助金额:$48.6万
-
财政年份:2014
-
负责人:BARBARA L. KEE
-
依托单位:
E and Id protein function in natural killer T cell differentiation
-
批准号:8735243
-
项目类别:
-
资助金额:$36.61万
-
财政年份:2013
-
负责人:BARBARA L. KEE
-
依托单位:
GATA3 deregulation and T cell transformation in E2A-/- mice
-
批准号:8265238
-
项目类别:
-
资助金额:$23.4万
-
财政年份:2011
-
负责人:BARBARA L. KEE
-
依托单位:
GATA3 deregulation and T cell transformation in E2A-/- mice
-
批准号:8189155
-
项目类别:
-
资助金额:$19.5万
-
财政年份:2011
-
负责人:BARBARA L. KEE
-
依托单位:
Mechanisms of Lymphocyte Gene Regulation by E2A and Notch1
-
批准号:7835645
-
项目类别:
-
资助金额:$38.04万
-
财政年份:2009
-
负责人:BARBARA L. KEE
-
依托单位:
Transcriptional Control of Hematopoiesis
-
批准号:7742075
-
项目类别:
-
资助金额:$39.0万
-
财政年份:2009
-
负责人:BARBARA L. KEE
-
依托单位:
Transcriptional Control of Hematopoiesis
-
批准号:7897688
-
项目类别:
-
资助金额:$38.61万
-
财政年份:2009
-
负责人:BARBARA L. KEE
-
依托单位:
国内基金
海外基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
-
批准号:2022J011295
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:王亚伟
-
依托单位:
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
-
批准号:30801055
-
项目类别:青年科学基金项目
-
资助金额:19.0万元
-
批准年份:2008
-
负责人:王丽梅
-
依托单位: